RxDoctor Payments Data

Travis Taylor

Optometrist · South Charleston, WVNPI 1134110851

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 24.4% of the total.

$1,613in general payments, 2019–2025

Across 39 payments — averaging $41.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$393
  • Alcon$335
  • Sun Pharmaceutical Industries Inc.$322
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$205
  • Johnson & Johnson Vision Care, Inc.$118
  • Dompe US, Inc.$117
  • plus $122 from 2 others
$62,244in ownership & investment interests, 2019–2025

Across 5 payments — averaging $12,449 each. An ownership or investment interest held by the physician or an immediate family member.

  • The North Carolina Mutual Wholesale Drug Company Inc$62K

What the payments were for

  • Food & beverage$1,51494%
  • Entertainment$996%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,613 in reported general payments places this provider in the 65th percentile of 210 optometrist providers in West Virginia.

See all optometrist providers in West Virginia

Medicare billing

Part B allowed, 2024
$25,089
Medicare patients
181
Services billed
356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Brimonidine Tartrate60$1,036
Latanoprost73$849
MoxifloxacinMoxifloxacin Hcl15$367
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat12$134
Timolol Maleate24$116

Paid to pharmacies, not to this prescriber.

Other optometrist in South Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →